Steven Altschuler

Steven M.
Altschuler was the founder of Spark Therapeutics, Inc., founded in 2013, where the title held was Chairman from 2013 to 2019.
Dr. Altschuler is also the founder of Corner Therapeutics, Inc...
Current jobs include Chairman at Stellular Bio, Inc., Chairman at AsclepiX Therapeutics LLC since 2019, Chairman at Azura Ophthalmics Ltd. since 2021, Chairman at Lexeo Therapeutics, Inc. since 2021, Director at Free Library of Philadelphia, Director at The GAVI Campaign, Director at Affinivax, Inc., Managing Director-Healthcare Ventures at Ziff Capital Partners LLC since 2018, Director at Imvax, Inc., Director at Innovative Genomics Institute, Independent Trustee at The Brigham & Women's Hospital, Inc., and Independent Trustee at Brigham & Women's Physician Group.
Former jobs include President & Chief Executive Officer at The Children's Hospital of Philadelphia Foundation from 2000 to 2015, President & Chief Executive Officer at University of Miami Health System from 2016 to 2017, Chief Executive Officer at The Children's Hospital of Philadelphia from 2000 to 2015, Chairman-Pediatrics Department at Perelman School of Medicine, Chairman at 89bio, Inc. from 2020 to 2025, Independent Director at Covista, Inc. from 2018 to 2020, Director at University Healthsystem Consortium, Inc., Director at Mead Johnson Nutrition Co. from 2009 to 2017, Independent Director at Mead Johnson Nutrition Co. from 2011 to 2017, Independent Director at WW International, Inc. from 2012 to 2025, Independent Director at Orchard Therapeutics Plc from 2020 to 2024, Executive Vice President-Healthcare at Miami University from 2016 to 2017, and Trustee at Children's Miracle Network from 2010 to 2012.
Education includes undergraduate and doctorate degrees from Case Western Reserve University.